Subjects:
Free Research Articles
On page 676 in the paragraph that begins “The second-generation BTKi acalabrutinib,” the last sentence “Notably, in the subgroup of 26 patients with blastoid/pleomorphic MCL, PFS was 15.2%” should read “Notably, in the subgroup of 26 patients with blastoid/pleomorphic MCL, median PFS was 15.2 months.”
© 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2025
